Robotics Reviewed

NantWorks: Robotics Investor Profile

NantWorks is the parent company of businesses founded by Dr. Patrick Soon-Shiong, the scientist behind the cancer drug Abraxane, and led Multiply Labs' October 2026 round.

TypeHolding company of Dr. Patrick Soon-Shiong
Based inUnited States
Robotics deals this month1

Who NantWorks is

NantWorks is the parent of private and public companies in health and life sciences, energy and renewables, and connectivity. Its founder, Dr. Patrick Soon-Shiong, invented Abraxane, the first human nanoparticle chemotherapy drug.1

Deals this month

NantWorks robotics deals, Sep 28 to Nov 2, 2026
CompanyRoundAmountRoleAnnounced
Multiply LabsSeries B$75MLead investorOctober 6, 20262

Robotics bet this month

Dr. Soon-Shiong and NantWorks led Multiply Labs' $75 million Series B on October 6, 2026, the largest round in the company's history and one that took its total above $100 million.2

The fit is with health and life sciences, one of NantWorks' three pillars. Multiply Labs says its robots cut cost per dose by 74%, a company figure that still needs independent results at commercial scale.2,1

Sources

  1. NantWorks, Homepage, accessed November 2, 2026
  2. Multiply Labs, Multiply Labs raises $75 million Series B, October 6, 2026, accessed November 2, 2026

More investors

See the list

Perceptive Advisors

Life science investment firm

Mercato Partners

Growth-stage investment firm

Avego

Healthcare investment firm

Catalio Capital Management

Healthcare and AI investment firm